What is the morphine (ME) equivalent for a fentanyl (Duragesic) patch and hydromorphone (Dilaudid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Morphine Equivalents for Fentanyl Patch and Hydromorphone

For fentanyl transdermal patches, use approximately 100:1 ratio (oral morphine mg/day : fentanyl mcg/hour), and for hydromorphone, use a 5:1 ratio (oral morphine : oral hydromorphone) or 3:1 ratio (oral morphine : parenteral hydromorphone). 1, 2

Fentanyl Transdermal Patch Conversion

Standard Conversion Ratios

  • The FDA-approved conversion uses approximately 100:1 ratio where 60-134 mg/day oral morphine converts to 25 mcg/hour fentanyl patch 2
  • For 135-224 mg/day oral morphine, use 50 mcg/hour fentanyl patch 2
  • For 225-314 mg/day oral morphine, use 75 mcg/hour fentanyl patch 2
  • For 315-404 mg/day oral morphine, use 100 mcg/hour fentanyl patch 2

Parenteral Fentanyl to Transdermal Conversion

  • When converting from continuous IV fentanyl infusion to transdermal fentanyl, use a straight 1:1 ratio (mcg of parenteral fentanyl = mcg/hour of transdermal fentanyl) 1, 3
  • Some patients may require patch replacement every 48 hours instead of the standard 72 hours 1

Important Caveats for Fentanyl Conversion

  • The conversion ratio varies significantly with dose: at lower morphine doses, the ratio may be closer to 28:1 to 39:1, while at higher doses it approaches 47:1 4
  • Research suggests that for low-dose conversions (morphine 16.6 mg/day), the ratio is approximately 28:1, not the commonly cited 50:1 or 100:1 4
  • Always reduce the calculated equianalgesic dose by 25-50% when switching between opioids to account for incomplete cross-tolerance 1, 5
  • Heat sources (heating pads, electric blankets) accelerate fentanyl absorption and are contraindicated 1

Hydromorphone Conversion

Oral Hydromorphone

  • Oral morphine to oral hydromorphone ratio is approximately 5:1 2
  • 8-17 mg/day oral hydromorphone = 25 mcg/hour fentanyl patch 2
  • 17.1-28 mg/day oral hydromorphone = 50 mcg/hour fentanyl patch 2
  • 28.1-39 mg/day oral hydromorphone = 75 mcg/hour fentanyl patch 2
  • 39.1-51 mg/day oral hydromorphone = 100 mcg/hour fentanyl patch 2

Parenteral Hydromorphone

  • Oral morphine to IV/IM hydromorphone ratio is approximately 3:1 (oral:parenteral) 2
  • 1.5-3.4 mg/day IV hydromorphone = 25 mcg/hour fentanyl patch 2
  • 3.5-5.6 mg/day IV hydromorphone = 50 mcg/hour fentanyl patch 2
  • 5.7-7.9 mg/day IV hydromorphone = 75 mcg/hour fentanyl patch 2
  • 8-10 mg/day IV hydromorphone = 100 mcg/hour fentanyl patch 2

Clinical Considerations for Hydromorphone

  • Hydromorphone is preferred for patients with significant morphine adverse effects or severe renal dysfunction 6
  • When converting to subcutaneous or IV morphine from oral, use a 3:1 ratio (oral:parenteral) 5

Critical Safety Principles

Dose Reduction for Cross-Tolerance

  • Always reduce the calculated equianalgesic dose by 25-50% when rotating between different opioids 1, 5
  • The CDC warns against using calculated morphine equivalent doses directly without this reduction 5

Conversion Table Limitations

  • These conversion tables are unidirectional: they convert TO fentanyl patch but should NOT be used to convert FROM fentanyl patch to other opioids, as this will overestimate the new opioid dose and risk fatal overdose 2
  • There is significant inter-patient variability in opioid potency—it is safer to underestimate requirements and provide rescue medication than to overestimate 2
  • Significant variation exists among clinicians in performing these conversions, particularly for fentanyl and methadone 7

Breakthrough Pain Management

  • Prescribe additional doses of approximately 10-20% of the 24-hour dose for breakthrough pain 5
  • More frequent assessment and titration are needed for actively dying patients 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dosis Obat Analgesik

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Opioid Dose Conversion for End-of-Life Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Analgesia in the intensive care unit. Pharmacologic and pharmacokinetic considerations.

Critical care nursing clinics of North America, 2001

Research

Variability in Opioid Equivalence Calculations.

Pain medicine (Malden, Mass.), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.